Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

HIV

UNC Lineberger Comprehensive Cancer CenterSmall moleculePhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the HIV cohort.

Asset / SponsorPhaseRating
tenofovir
Giovanni Di Perri
Phase 4BB
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2BB
Raltegravir
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 4BB
Harvoni
University of California, San Francisco
Phase 4BB
Evomela
AIDS Malignancy Consortium
Phase 2BB

View all 26 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →